Effect of lipoxygenase inhibition on mucous glycoprotein secretion from chinchilla middle ear epithelial cells in vitro

Annals of Otology, Rhinology and Laryngology

Volumn 105, Issue 11, 1996, Pages 916-921

  Kim, Youngki ^a   Ondrey, Frank ^a   Lin, Jizhen ^a,b   Lees, Chris ^a   Juhn, Steven K ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b NONE   (United States)

Author keywords

lipoxygenase; middle ear epithelial cells in vitro; mucous glycoprotein secretion; otitis media with effusion; platelet activating factor

Indexed keywords

ARACHIDONIC ACID; INDOMETACIN; LIPOXYGENASE; LIPOXYGENASE INHIBITOR; MUCIN; N [1 (4 BENZYLOXYPHENYL)ETHYL]ACETOHYDROXAMIC ACID; NORDIHYDROGUAIARETIC ACID; PROSTAGLANDIN SYNTHASE INHIBITOR; THROMBOCYTE ACTIVATING FACTOR;

ANIMAL CELL; ARACHIDONIC ACID METABOLISM; ARTICLE; CELL SECRETION; CHINCHILLA; CONTROLLED STUDY; ENZYME INHIBITION; EPITHELIUM CELL; MIDDLE EAR; NONHUMAN; PRIORITY JOURNAL;

EID: 2642589597     PISSN: 00034894     EISSN: None     Source Type: Journal    
DOI: 10.1177/000348949610501113     Document Type: Article

References (28)

1. Page CP. The role of platelet-activating factor in asthma. J Allergy Clin Immunol 1988;81:144-52.
2. Barnes PJ. Platelet-activating factor and asthma. J Allergy Clin Immunol 1988;81:152-60.
3. Morley J. Platelet-activating factor and asthma. Agents Actions 1986;19:100-8.
4. Salari H, Wong A. Generation of platelet-activating factor (PAF) by a human lung epithelial cell line. Eur J Pharmacol 1990;175:253-9.
5. Rhee C-K, Jung TTK, Miller S, Weeks D. Experimental otitis media with effusion induced by platelet activating factor. Ann Otol Rhinol Laryngol 1993;102:600-5.
6. Lin J, Kim Y, Juhn SK, Lees C. Effects of platelet-activating factor on secretion of mucous glycoprotein from cultured chinchilla middle ear epithelial cells. Eur Arch Otorhinolaryngol 1995;252:92-6.
7. Lin JZ, Kim Y, Lees C, Juhn SK. Effect of platelet-activating factor receptor blockage on mucous glycoprotein secretion in cultured chinchilla middle ear epithelial cells. Acta Otolaryngol (Stockh) (in press).
8. Jung TTK. Prostaglandins, leukotrienes, and other arachidonic acid metabolites in the pathogenesis of otitis media. Laryngoscope 1988;98:980-93.
9. Jung TTK, Juhn SK, Gerrard JM. Identification of prostaglandins and other arachidonic acid metabolites in experimental otitis media. Prostaglandins Leukotrienes Med 1982;8:249-61.
10. Adler KB, Schwarz JE, Anderson WH, Welton AF. Platelet-activating factor stimulates secretion of mucin by expiants of rodent airways in organ culture. Exp Lung Res 1987;13:25-43.
11. Adler KB, Akley NJ, Glasgow WC. Platelet-activating factor provokes release of mucin-like glycoproteins from guinea pig respiratory epithelial cells via a lipoxygenase-dependent mechanism. Am J Respir Cell Mol Biol 1992;6:550-6.
12. Amesara R, Kim Y, Sano S, Harada T, Juhn SK. Primary cultures of middle ear epithelial cells from chinchillas. Eur Arch Otorhinolaryngol 1992;249:164-7.
13. Harada T, Juhn SK, Sakakura Y. Biochemical characterization of mucous glycoproteins secreted by chinchilla middle ear epithelial cells in vitro. Eur Arch Otorhinolaryngol 1993; 250:183-5.
14. Voelkel NF, Worthen S, Reeves JT, Henson PM, Murphy RC. Nonimmunologic production of leukotrienes by platelet-activating factor. Science 1982;218:286-9.
15. Honda Z, Nakamura M, Miki I, et al. Cloning by functional expression of platelet activating factor receptor from guinea pig lung. Nature 1991;349:342-6.
16. Hwang S-B. Specific receptors of platelet-activating factor, receptor heterogeneity, and signal transduction mechanisms. J Lipid Mediat 1990;2:123-58.
17. Koltai M, Hosford D, Guinot P, Esanu A, Braquet P. Platelet activating factor (PAF). A review of its effects, antagonists and possible future clinical implication (part I). Drugs 1991; 42:9-29.
18. Terashita Z, Tsushima S, Yoshioka Y, Nomura H, Inada Y, Nishikawa K. CV-3988 - a specific antagonist of platelet activating factor (PAF). Life Sci 1983;32:1975-82.
19. Stremler KE, Stafforini DM, Prescott SM, McIntyre TM. Human plasma platelet-activating factor acetylhydrolase. Oxidatively fragmented phospholipids as substrates. J Biol Chem 1991;266:11095-103.
20. Prescott SM, Zimmerman GA, McIntyre TM. Platelet-activating factor. J Biol Chem 1990;265:17381-4.
21. Snyder F. Platelet-activating factor and related lipid mediators. New York, NY: Plenum Press, 1987.
22. Tessner TG, O'Flaherty JT, Wykle RL. Stimulation of platelet-activating factor synthesis by a nonmetabolizable bioactive analog of platelet-activating factor and influence of arachidonic acid metabolites. J Biol Chem 1989;264:4794-9.
23. Doebber TW, Wu MS. Platelet-activating factor (PAF) stimulates the PAF-synthesizing enzyme acetyl-CoA: 1-alkyl-sn-glycero-3-phosphocholine O2-acetyl transferase and PAF synthesis in neutrophils. Proc Natl Acad Sci USA 1987;84:7557-61.
24. Ezra D, Laurindo FRM, Czaja JF, Snyder F, Goldstein RE, Feuerstein G. Cardiac coronary consequences of intracoronary platelet-activating factor infusion in the domestic pig. Prostaglandins 1987;34:41-57.
25. Lee T-C, Malone B, Snyder F. Stimulation of calcium uptake by 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine (platelet-activating factor) in rabbit platelets: possible involvement of the lipoxygenase pathway. Arch Biochem Biophys 1983;223:33-9.
26. Brock TA, Gimbrone MA Jr. Platelet-activating factor alters calcium homeostasis in cultured vascular endothelial cell. Am J Physiol 1986;252:1086-92.
27. Phillips TE, Stanley CM, Wilson J. The effect of 16,16-dimethyl prostaglandin E2 on proliferation of an intestinal goblet cell line and its synthesis and secretion of muicin glycoproteins. Prostaglandins Leukot Essent Fatty Acids 1993;48:423-8.
28. Amesara R, Kim Y, Juhn SK. Effects of arachidonic acid metabolites on mucous glycoprotein production in middle ear epithelial cell culture. In: Lim DJ, Bluestone CD, Klein JO, Nelson JD, eds. Recent advances in otitis media. Philadelphia, Pa: BC Decker, 1991:411-3.